Eri Toda Kato

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Glycemic Control

Acute Myocardial Infarction

Top Venues

European heart journal. Cardiovascular pharmacotherapy

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

International journal of heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Eri Toda Kato, Koji Hasegawa, Koh Ono
The Impact of SGLT2 Inhibitors in Post-Myocardial Infarction Management: Insights from EMPACT-MI and DAPA-MI Trials. European heart journal. Cardiovascular pharmacotherapy (2024)
Takanori Aizawa, Yuko Wada, Kanae Hasegawa, Hai Huang, Tomohiko Imamura, Jingshan Gao, Asami Kashiwa, Hirohiko Kohjitani, Megumi Fukuyama, Koichi Kato, Eri Toda Kato, Takashi Hisamatsu, Seiko Ohno, Takeru Makiyama, Takeshi Kimura, Minoru Horie
Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Eri Toda Kato, Koh Ono, Basil S Lewis
SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from AHA. European heart journal. Cardiovascular pharmacotherapy (2023)
Eri Toda Kato, Basil S Lewis, Koh Ono
GLP-1 receptor agonists: new game changing drugs in patients with heart failure with preserved ejection fraction and obesity. European heart journal. Cardiovascular pharmacotherapy (2023)
Eri Toda Kato, Takeshi Kimura
Sodium-glucose Co-transporters-2 Inhibitors and Heart Failure: State of the Art Review and Future Potentials. International journal of heart failure 2 (1) (2020)